Skip to main content
Fig. 1 | BMC Nephrology

Fig. 1

From: METTL3 enhances NSD2 mRNA stability to reduce renal impairment and interstitial fibrosis in mice with diabetic nephropathy

Fig. 1

NSD2 is poorly expressed in patients with DN. A serum levels of FBG, SCr, S-Cys-C, 24-h U-protein, and U-Cys-C in patients with DN and in healthy individuals determined using an automatic biochemical analyzer; B serum level of NSD2 in patients with DN and in healthy controls determined by RT-qPCR; C correlations between NSD2 and the levels of FBG, SCr, S-Cys-C, 24-h U-protein, and U-Cys-C in patients with DN. There were 25 healthy individuals and 34 patients. Data were collected from three independent experiments and expressed as the mean ± SD. Differences were analyzed by the unpaired t test (A-B). In panel C, the correlations were analyzed by Pearson’s correlation analysis. *p < 0.05

Back to article page

BMC Nephrology

ISSN: 1471-2369

Contact us